Lazard Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $712M | Buy |
|
|||||
|
2025
Q1 | $632M | Sell |
|
|||||
|
2024
Q4 | $579M | Sell |
|
|||||
|
2024
Q3 | $608M | Sell |
|
|||||
|
2024
Q2 | $579M | Buy |
|
|||||
|
2024
Q1 | $509M | Sell |
|
|||||
|
2023
Q4 | $510M | Sell |
|
|||||
|
2023
Q3 | $470M | Sell |
|
|||||
|
2023
Q2 | $497M | Sell |
|
|||||
|
2023
Q1 | $571M | Sell |
|
|||||
|
2022
Q4 | $588M | Buy |
|
|||||
|
2022
Q3 | $486M | Sell |
|
|||||
|
2022
Q2 | $472M | Buy |
|
|||||
|
2022
Q1 | $453M | Buy |
|
|||||
|
2021
Q4 | $421M | Buy |
|
|||||
|
2021
Q3 | $422M | Buy |
|
|||||
|
2021
Q2 | $415M | Sell |
|
|||||
|
2021
Q1 | $380M | Buy |
|
|||||
|
2020
Q4 | $344M | Buy |
|
|||||
|
2020
Q3 | $330M | Buy |
|
|||||
|
2020
Q2 | $203M | Buy |
|
|||||
|
2020
Q1 | $53.2M | Sell |
|
|||||
|
2019
Q4 | $78.1M | Sell |
|
|||||
|
2019
Q3 | $77.2M | Sell |
|
|||||
|
2019
Q2 | $82.8M | Buy |
|
|||||
|
2019
Q1 | $46M | Sell |
|
|||||
|
2018
Q4 | $45.6M | Buy |
|
|||||
|
2018
Q3 | $5.53M | Sell |
|
|||||
|
2018
Q2 | $5.32M | Buy |
|